Trial intelligence / Profile preview

Timing of Adductor Canal Block in Total Knee Arthroplasty

NCT02908711Phase 4Completed

Sponsor
Rabin Medical Center
Start
Oct 2016
Primary completion
Jan 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Rabin Medical Center. Primary endpoint: Pain score associated with knee motion following TKA. Started Oct 2016; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02908711.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02908711.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call